Table 3.
Pharmacological properties of Equisetum genus stratified by effect, key findings, and species.
| Effect | Key findings | Species | Reference |
|---|---|---|---|
| Diuretic activity | Increased excretion of sodium, potassium, and chloride | Equisetum fluviatile | [75] |
| Equisetum hyemale var. affine | |||
| Equisetum giganteum | |||
| Equisetum myriochaetum | |||
| Increased excretion of sodium, potassium, and chloride∗ | Equisetum bogotense | [18] | |
| No effects on the urinary excretion of electrolytes∗ | Equisetum arvense L. | [13] | |
| Urinary bladder disorders | Increased interval between urinary bladder contractions and decreased bladder contraction pressure | Equisetum arvense L. | [67] |
| Urinary incontinence | Improvement in urinary incontinence episodes; day-time urination frequency; and gain in nocturnal urinary frequency∗ | CELcomplex® (Cucurbita pepo L.; Equisetum arvense L.; and Linum usitatissimum L.) | [68] |
| State of hydration and bloating sensation | Decreased extracellular water and fat mass∗ | Formula (Fraxinus ornus L.; Ananas comosus L.; Betula pendula R.; Equisetum arvense L.; Urtica dioica L; and Pilosella officinarum L. Vaill.) | [69] |
| Nephrolithiasis | Lower calcium oxalate crystals | Formula (Herniaria glabra L.; Agropyron repens; Equisetum arvense L.; and Sambucus nigra L.) | [70] |
| Antinociceptive effect | Inhibitory action on chemically induced acute pain test | Equisetum arvense L. | [84] |
| Reduction of clinical chronic musculoskeletal pain∗ | Equisetum arvense L. | [86] | |
| Anti-inflammatory effect | Anti-inflammatory action on COPD model | Equisetum arvense L. | [85] |
| Reduction of antigen-induced arthritis model | Equisetum giganteum L. | [9] | |
| Cytotoxic and anticancer effect | Reduction in cell viability of cancer cells | Equisetum arvense L. | [87–90] |
| Effect on bone diseases | Increase in calcium absorption | Equisetum arvense L. | [92] |
| Proliferation of osteoblasts or inhibitory action in osteoclasts | Equisetum arvense L. | [38, 94] | |
| Bone resorption markers of rats | Equisetum arvense L. | [95] | |
| Bone mineral density of rats | Equisetum arvense L. | [95, 96] | |
| Antidiabetic | Beneficial effects in streptozotocin-induced diabetic rats | Equisetum myriochaetum Schlecht. and Cham. | [66] |
| Clinically beneficial to recently diagnosed type 2 diabetic patients∗ | Equisetum myriochaetum Schlecht. and Cham. | [99] | |
| Beneficial effects in alloxan-induced diabetic rabbits | Equisetum giganteum L. | [97] | |
| Reduction in oxidative stress | Equisetum arvense L. | [101] | |
| Antioxidant and antimicrobial | Antimicrobial activity | Equisetum giganteum L. | [10, 28, 98] |
| Antioxidant and antimicrobial of supercritical fluid extraction | Equisetum telmateia Ehrh. | [40] | |
| Bactericidal, fungicidal, and antiprotozoal effect | Equisetum hyemale L. | [61, 100] | |
| Bactericidal and fungicidal activity | Equisetum arvense L. | [91] | |
| Radical scavenger activity | Equisetum arvense L. | [102] | |
| Equisetum ramosissimum Desf. and Equisetum telmateia Ehrh. | |||
| Radical scavenger activity and antimicrobial activity | Equisetum arvense L. | [24] | |
| Equisetum sylvaticum L. | |||
| Equisetum fluviatile L. | |||
| Equisetum palustre L. | |||
| Equisetum telmateia Ehrh. | |||
| Radical scavenger activity and antimicrobial activity | Equisetum telmateia Ehrh. | [47] | |
| Effects on central nervous system | Anticonvulsant and sedative effects | Equisetum arvense L. | [103] |
| Prolonged the ketamine-induced total sleeping time and decreased the locomotor activity in mice | Equisetum arvense L. | [104] | |
| Antiulcer | Gastroprotective potential against different ulcerogenic agents | Equisetum palustre L. | [35] |
∗Clinical study.